PM

Prosight Management Portfolio holdings

AUM $416M
1-Year Est. Return 4.49%
This Quarter Est. Return
1 Year Est. Return
+4.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$410M
AUM Growth
+$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$34.3M
2
+$12.8M
3
+$12M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$8.57M
5
CON
Concentra Group Holdings
CON
+$6.42M

Top Sells

1
+$7.6M
2
+$7.29M
3
+$6.93M
4
ABCL icon
AbCellera Biologics
ABCL
+$6.28M
5
BBIO icon
BridgeBio Pharma
BBIO
+$5.93M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHC icon
26
Acadia Healthcare
ACHC
$1.45B
$4.81M 1.17%
211,816
-78,184
CRBP icon
27
Corbus Pharmaceuticals
CRBP
$194M
$4M 0.98%
579,893
+4,757
RCKT icon
28
Rocket Pharmaceuticals
RCKT
$330M
$3.87M 0.94%
1,580,588
+100,588
SGHT icon
29
Sight Sciences
SGHT
$376M
$3.6M 0.88%
871,687
-97,600
AXGN icon
30
Axogen
AXGN
$1.09B
$3.07M 0.75%
+282,809
LNTH icon
31
Lantheus
LNTH
$3.52B
$2.83M 0.69%
+34,576
MURA icon
32
Mural Oncology
MURA
$36.2M
$2.22M 0.54%
900,000
+477,257
PRTA icon
33
Prothena Corp
PRTA
$535M
$1.63M 0.4%
267,800
-140,322
KIDS icon
34
OrthoPediatrics
KIDS
$419M
$1.58M 0.39%
+73,647
PLRX icon
35
Pliant Therapeutics
PLRX
$103M
$971K 0.24%
837,400
+503,137
RNTX
36
Rein Therapeutics
RNTX
$32.4M
$599K 0.15%
427,919
-2,081
OKUR
37
OnKure Therapeutics
OKUR
$42.4M
$382K 0.09%
159,692
-26,878
ERAS icon
38
Erasca
ERAS
$732M
$305K 0.07%
240,295
-706,815
PEPG icon
39
PepGen
PEPG
$326M
$271K 0.07%
+243,980
SYRE icon
40
Spyre Therapeutics
SYRE
$1.82B
– –
-74,921
SDGR icon
41
Schrodinger
SDGR
$1.3B
– –
-385,000
ISRG icon
42
Intuitive Surgical
ISRG
$195B
– –
-14,000
IMNM icon
43
Immunome
IMNM
$1.57B
– –
-23,618
HAE icon
44
Haemonetics
HAE
$3.44B
– –
-65,400
BPMC
45
DELISTED
Blueprint Medicines
BPMC
– –
-36,512
ADUS icon
46
Addus HomeCare
ADUS
$2.02B
– –
-24,045
ABCL icon
47
AbCellera Biologics
ABCL
$1.1B
– –
-2,815,652
1
2